Showing results (2621-2630 of 8,257) with videos related to
Sort By:
Pageof 826
Haematologica|September 8, 1999
IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndromeO Safa, L Crippa, P Della Valle, et al.Haematologica|September 8, 1999
Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo OsseoI Majolino, M Vignetti, G Meloni, et al.Haematologica|July 16, 1999
Serum phospholipids are the main environmental determinants of activated factor VII in the most common FVII genotype. European Union Concerted Action "Clotart"G Mariani, F Bernardi, R Bertina, et al.Haematologica|July 16, 1999
The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factorM F Dresse, M Boogaerts, C Vermylen, et al.Haematologica|July 16, 1999
Diagnostic role of gallium scanning in the management of lymphoma with mediastinal involvementP L Zinzani, M Magagnoli, R Franchi, et al.Haematologica|February 22, 2000
VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study GroupG Santini, P Coser, A M Congiu, et al.Haematologica|April 11, 2000
Intracardiac thrombosis in a case of Behcet's disease associated with the prothrombin 20210G-A mutationA Vayá, M J Forner, A Estellés, et al.Haematologica|December 20, 1999
Assessment of distribution of CD34 epitope classes in fresh and cryopreserved peripheral blood progenitor cells and acute myeloid leukemic blastsF Lanza, S Moretti, B Castagnari, et al.Haematologica|December 20, 1999
How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?P L Zinzani, M Martelli, M Magagnoli, et al.Haematologica|December 20, 1999
Salvage chemotherapy with mini-BEAM for relapsed or refractory Hodgkin's disease prior to autologous peripheral blood stem cell transplantationM C Fernández-Jiménez, M A Canales, E Ojeda, et al.Pageof 826